Meritxell Costa Grau

Mrs. Meritxell Costa Grau

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
PJPankaj Mangalkumar Joshi
Pankaj Mangalkumar Joshi
MGMeritxell Costa Grau
Meritxell Costa Grau
PKPawan Kandhari
Pawan Kandhari
STSaurabh Mahesh Thakkar
Saurabh Mahesh Thakkar
EOEmmanuel Ugbede Oyibo
Emmanuel Ugbede Oyibo
SKSanjay Balwant Kulkarni
Sanjay Balwant Kulkarni
Pelvic fracture urethral injury (PFUI) represents one of the most challenging entities in reconstructive urology. It predominantly affects the bulbomembranous junction because of its anatomical vulnerability to shearing and compression forces during pelvic trauma. These injuries often result from high-energy accidents, with associated pelvic instability and concomitant injuries, and frequently necessitate a multidisciplinary initial approach. Early management typically involves prompt suprapubic cystostomy (SPC) to divert urine, prevent further contamination, and allow stabilization of the patient. Delayed urethroplasty (DU) remaining the gold standard for definitive repair once the acute phase has resolved. Delayed repair most commonly consists of a perineal bulbomembranous anastomosis (BMA), a technique that has been extensively described and refined over decades, providing a tension-free anastomosis with consistently high success rates. In severe cases, however, where there is significant pelvic disruption, extensive urethral gaps, or difficult access due to scarring, an abdominoperineal approach may be required to achieve adequate exposure, mobilization, and excision of scar tissue. Complex PFUI scenarios, defined by dense periurethral fibrosis, long-segment defects, associated fistulae, or concomitant bladder neck injury, demand more advanced reconstructive strategies and are associated with lower success rates compared with primary BMA. Redo urethroplasty represents an even greater challenge due to altered anatomy, impaired vascularity, and a lack of healthy tissue available for mobilization. Common factors contributing to surgical failure include inadequate excision of fibrotic tissue, insufficient mobilization of the bulbar urethra, and poor tissue quality at the anastomotic site. When bulbar urethral necrosis (BUN) occurs or when the urethral gap cannot be bridged primarily, substitution techniques become necessary. Among these, the pedicled preputial tube has emerged as one of the most widely described and effective options, offering a robust vascularized tissue for reconstruction and demonstrating favorable long-term outcomes. Successful PFUI management therefore relies on individualized planning that integrates detailed preoperative imaging and refined surgical techniques tailored to the specific extent and complexity of the injury.

1 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ECEnric Carbonell
Enric Carbonell
CMClàudia Mercader
Clàudia Mercader
Héctor AlfambraHéctor Alfambra
Héctor Alfambra
PNPaulette Narvaez
Paulette Narvaez
EVEric Villalba
Eric Villalba
TVToni Vilaseca
Toni Vilaseca
Background and Objective: The role of urine cytology during follow-up for low-grade (LG) non-muscle-invasive bladder cancer (NMIBC) is not well established, although cytology has low sensitivity in detecting LG recurrences. Our study aims to evaluate the impact of urine cytology as a complementary method to cystoscopy during follow-up for LG NMIBC. Methods: Patients diagnosed with primary LG TaT1 bladder cancer (BC) between 2010 and 2020 were included. Patients were stratified according to the EAU NMIBC scoring model. Urine cytology was performed during follow-up cystoscopy. The outcomes of the study were BC recurrence and upgrading to high-grade (HG). Cytology utility was established by assessing whether its result led to management change. Results: We included 337 patients with LG TaT1 BC. EAU risk group distribution was low in 262 (77.7%), intermediate in 57 (16.9%), and high-risk in 18 (5.3%) cases. With a median follow-up of 5 years, 166 (49.3%) patients experienced recurrence. Cystoscopy was positive in 154 (92.8%) and suspicious in 12 (7.2%) cases. Urine cytology was positive in 33 (19.9%) cases but only changed management in 3 (0.89%), all with suspicious cystoscopy. Positive cytology at first recurrence was associated with higher risk of upgrading during follow-up (HR 2.781, p = 0.006) and lower upgrading-free survival (p = 0.001). Conclusions: The role of urine cytology to detect first recurrences during follow-up for primary LG TaT1 NMIBC might be limited to patients with non-conclusive lesions in the cystoscopy. A positive cytology at first recurrence is associated with a higher risk of upgrading to HG BC during follow-up.

22 August 2025 in Cancers
Verified
Journal Article
Open access
PDF file
VRValèria Richart
Valèria Richart
MGMeritxell Costa Grau
Meritxell Costa Grau
MMMaría Muní
María Muní
IAIgnacio Asiain
Ignacio Asiain
RSRafael Salvador
Rafael Salvador
CNCarlos Nicolau
Carlos Nicolau
Background/Objectives: Magnetic resonance imaging (MRI) and MRI–ultrasound (US) fusion-targeted biopsy have improved prostate cancer diagnosis, particularly for clinically significant disease. However, the added value of combining systematic biopsy with targeted biopsy remains debated. This study aimed to evaluate the diagnostic accuracy of MRI–US fusion-targeted and systematic transperineal biopsies in detecting prostate cancer and explore the correlation between PI-RADS score and histology. Methods: We retrospectively analyzed 356 patients with 452 MRI-detected lesions who underwent both MRI–US fusion-targeted and transperineal systematic biopsies between 2020 and 2023. Clinically significant prostate cancer (csPCa) was defined as International Society of Urological Pathology (ISUP) grade ≥ 2. Diagnostic performance metrics (sensitivity, specificity, and accuracy) were calculated for each technique using the combined result as a reference. Subgroup analysis was performed for patients under active surveillance. Results: Prostate cancer was diagnosed in 323 of 452 lesions (71%) and csPCa in 223 lesions (49%). Targeted biopsy demonstrated higher sensitivity (93.7%) and accuracy (79.9%) than systematic biopsy (85.7% sensitivity and 77.6% accuracy), although systematic biopsy provided slightly higher specificity. Systematic biopsy alone identified 8.2% of PCa cases missed by targeted biopsy and upgraded 9.9% of lesions to csPCa. csPCa detection increased with PI-RADS score (23% in PI-RADS 3 and 73% in PI-RADS 5). In active surveillance patients, csPCa was found in 65% of lesions. Conclusions: MRI–US fusion-targeted biopsy improves csPCa detection, but systematic biopsy remains valuable, especially for identifying additional or higher-grade disease. The combined approach provides an optimal diagnostic yield, supporting its continued use in both initial and repeat biopsy settings.

9 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
VRValèria Richart
Valèria Richart
MGMeritxell Costa Grau
Meritxell Costa Grau
MMMaría Muní
María Muní
IAIgnacio Asiain
Ignacio Asiain
RSRafael Salvador
Rafael Salvador
CNCarlos Nicolau
Carlos Nicolau
Background/Objectives: Magnetic resonance imaging (MRI) and MRI–ultrasound (US) fusion-targeted biopsy have improved prostate cancer diagnosis, particularly for clinically significant disease. However, the added value of combining systematic biopsy with targeted biopsy remains debated. This study aimed to evaluate the diagnostic accuracy of MRI–US fusion-targeted and systematic transperineal biopsies in detecting prostate cancer and to explore the correlation between PI-RADS score and histology. Methods: We retrospectively analyzed 356 patients with 452 MRI-detected lesions who underwent both MRI–US fusion-targeted and transperineal systematic biopsy between 2020 and 2023. Clinically significant prostate cancer (csPCa) was defined as ISUP grade ≥ 2. Diagnostic performance metrics (sensitivity, specificity, and accuracy) were calculated for each technique using the combined result as reference. Subgroup analysis was performed for patients under active surveillance. Results: Prostate cancer was diagnosed in 323 of 452 lesions (71%), and csPCa in 223 lesions (49%). Targeted biopsy demonstrated higher sensitivity (93.7%) and accuracy (79.9%) than systematic biopsy (85.7% sensitivity, 77.6% accuracy), although systematic biopsy provided slightly higher specificity. Systematic biopsy alone identified 8.2% of PCa cases missed by targeted biopsy, and upgraded 9.9% of lesions to csPCa. csPCa detection increased with PI-RADS score (23% in PI-RADS 3, 73% in PI-RADS 5). In active surveillance patients, csPCa was found in 65% of lesions. Conclusions: MRI–US fusion-targeted biopsy improves csPCa detection but systematic biopsy remains valuable, especially for identifying additional or higher-grade disease. The combined approach provides optimal diagnostic yield, supporting its continued use in both initial and repeat biopsy settings.

21 January 2026 in Basic and Clinical Andrology
Verified
Journal Article
Open access
PDF file
PJPankaj Mangalkumar Joshi
Pankaj Mangalkumar Joshi
PKPawan Kandhari
Pawan Kandhari
MGMeritxell Costa Grau
Meritxell Costa Grau
STSaurabh Thakkar
Saurabh Thakkar
EOEmmanuel Oyibo
Emmanuel Oyibo
SKSanjay Kulkarni
Sanjay Kulkarni
Background: Surgical correction of Peyronie’s disease often requires grafting techniques to restore penile anatomy and function. The bovine pericardial patch is a promising biomaterial due to its strength, elasticity, and biocompatibility. This study evaluates the safety, handling, and clinical outcomes associated with its use in tunical grafting procedures. Methods: A prospective, single-centre clinical study enrolled six patients with Peyronie’s disease requiring plaque incision and grafting. Data on surgical handling characteristics, postoperative outcomes, complications, and patient satisfaction were collected and analysed descriptively using standard statistical methods. Results: All surgeries were completed without intraoperative complications. Patch handling characteristics were rated as excellent across all surgical parameters. No adverse events, graft-related complications, or loss of penile function were observed during the follow-up period. Patient satisfaction was rated as very high at discharge and at one-month follow-up. Conclusions: Bovine pericardial tissue patch grafting demonstrated excellent safety, efficacy, and high satisfaction rates for surgical correction of Peyronie’s disease deformities. These findings support its wider clinical application, although larger studies with extended follow-up are warranted to confirm long-term outcomes.